Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olanzapine + ondansetron + dexamethasone for prevention of chemotherapy-induced nausea and vomiting in patients receiving doxorubicin plus cyclophosphamide
TCTR20190115002Phase 2Completed
- Sponsor
- Rajavithi Foundation
- Start
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of olanzapine in chemotherapy-induced nausea and vomiting (CINV), sponsored by Rajavithi Foundation. Started May 2016; status: completed.
02
Drugs
olanzapine
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on TCTR20190115002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20190115002.